awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38202691-2F6B2DAB-8179-4987-B790-7216FFAA7946
Q38202691-2F6B2DAB-8179-4987-B790-7216FFAA7946
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38202691-2F6B2DAB-8179-4987-B790-7216FFAA7946
Current Phase II antibody-drug conjugates for the treatment of lymphoid malignancies.
P2860
Q38202691-2F6B2DAB-8179-4987-B790-7216FFAA7946
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38202691-2F6B2DAB-8179-4987-B790-7216FFAA7946
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9393d1c521dfea1a4e9cdba6d51e21ac66024296
P2860
Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia.